Suppositories Market News: $2.05 Billion Forecast by 2030
The report "Suppositories Market by Type (Urethral, Rectal, Vaginal), Base (Oleaginous, Aqueous, Emulsifying), Prescription (OTC, Prescribed), Application (Analgesic, Laxatives, Anti-fungal, Nasal Decongestants), Patient (Adult & Pediatrics) - Global Forecast to 2030", is projected to reach USD 2.05 billion by 2030 from USD 1.63 billion in 2025, at a CAGR of 4.7% during the forecast period.
Browse 269 market data Tables and 65 Figures spread through 270 Pages and in-depth TOC on "Suppositories Market - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/suppositories-market-64269069.html
The rising incidence of chronic diseases, combined with an expanding elderly demographic and the pressing need for cost-effective healthcare solutions, drives the growth in the suppositories market. According to projections from the United Nations Population Fund (UNFPA), the proportion of individuals aged 65 and older is anticipated to increase from 10.3% of the global population in 2024 to 20.7% by 2074. This aging population exerts significant pressure on healthcare systems, particularly as budgets remain constrained. The prevalence of chronic health issues, including inflammatory bowel diseases (IBD), gastrointestinal disorders, hemorrhoids, constipation, inflammation, and pain, catalyzes the demand for suppositories. Furthermore, the increasing need for targeted drug delivery is expected to further propel market growth during the forecast period.
The rectal segment registered the largest market share in 2024.
The suppositories market, by type, is categorized into rectal, vaginal, and urethral, with the rectal segment commanding the largest market share. This predominance is attributed to the broad therapeutic coverage and high patient acceptance by geriatric and pediatric populations. Rectal suppositories are commonly prescribed for pain and fever, constipation, and inflammatory bowel diseases like ulcerative colitis. Due to this diverse range of indications, rectal suppositories are mainly used for acute and chronic care, fueling market growth demand.
The anti-bacterial and anti-fungal segment accounted for the second-largest market share in 2024.
Based on application, the suppositories market is segmented into analgesics and antipyretics, laxatives, anti-bacterial and anti-fungal, anti-emetics, hemorrhoid treatments, and others (including anti-malarial, nasal decongestants, and others). The anti-bacterial and anti-fungal segment held the second largest market share primarily due to their significant role in treating vaginal and rectal infections. The increasing prevalence of vaginal candidiasis, and bacterial vaginosis increasingly demand vaginal suppositories containing clotrimazole or metronidazole. Moreover, increasing awareness about women's health and growing demand for targeted drug delivery further support the growth of this segment.
North America commanded the largest market share in 2024.
On the basis of region, the suppositories market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The North American market has successfully secured a substantial share, driven by several key factors. One major contributor is the growth in the geriatric population, which is leading to an increased demand for healthcare services and targeted drug delivery solutions. Alongside this demographic shift, there has been a notable rise in the prevalence of chronic diseases that require regular monitoring and management. Furthermore, supportive government initiatives aimed at improving healthcare accessibility also have a positive impact on the market. The strategic expansion of key players in the North American market, which includes both established companies and emerging startups, is anticipated to further bolster market growth. The active presence of these industry leaders enhances competition and drives innovation in product development, ultimately benefiting patients and healthcare providers alike. Overall, these factors collectively signify a robust growth trajectory for the suppositories market in North America.
Key Players
As of 2024, suppositories market was dominated by Bayer AG (Germany), Novartis AG (Switzerland), Sanofi (France), Zydus Group (India), Bliss GVS Pharma Limited (India), Church & Dwight Co., Inc. (US), Bausch Health Companies Inc. (Canada), Teva Pharmaceutical Industries Ltd. (Israel), Sun Pharmaceutical Industries Ltd. (India), Adcock Ingram (South Africa), Aspen Holdings (South Africa), Julphar (UAE), Cipla (India), Haleon Group of Companies (UK), and Prestige Consumer Healthcare (US), among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Suppositories Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
